Literature DB >> 27403549

Resistance Training: Physiological Responses and Adaptations (Part 3 of 4).

S J Fleck, W J Kraemer.   

Abstract

In brief: The authors continue their discussion of the physiological responses and adaptations that occur as a result of resistance training. (The discussion began in part 2; part 1 presented the basics of resistance training.) Body composition, neural and cardiovascular adaptations, serum lipid profile, blood pressure, and the endocrine system are covered in this article. The conclusion is that conventional weight training brings about little change in endurance capabilities, but that high-volume, low-load training enhances endurance capabilities and may cause serum lipid profile changes that reduce cardiovascular risk.

Entities:  

Year:  1988        PMID: 27403549     DOI: 10.1080/00913847.1988.11709506

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  5 in total

Review 1.  The role of resistance exercise intensity on muscle fibre adaptations.

Authors:  Andrew C Fry
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 2.  Resistance training during preadolescence. Issues and controversies.

Authors:  C J Blimkie
Journal:  Sports Med       Date:  1993-06       Impact factor: 11.136

3.  Acute Physiological Responses to High-Intensity Resistance Circuit Training vs. Traditional Strength Training in Soccer Players.

Authors:  Cristian Marín-Pagán; Anthony J Blazevich; Linda H Chung; Salvador Romero-Arenas; Tomás T Freitas; Pedro E Alcaraz
Journal:  Biology (Basel)       Date:  2020-11-07

4.  Comparison of aerobic and combined aerobic and resistance training on low-density lipoprotein cholesterol concentrations in men.

Authors:  Ina Shaw; Brandon S Shaw; Oleksandr Krasilshchikov
Journal:  Cardiovasc J Afr       Date:  2009 Sep-Oct       Impact factor: 1.167

5.  Relationship between resistance training and lipoprotein profiles in sedentary male smokers.

Authors:  I Shaw; B S Shaw
Journal:  Cardiovasc J Afr       Date:  2008 Jul-Aug       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.